About

Worldwide CardioDiabetes is a subdivision of the Worldwide Initiative for Diabetes Education (Worldwide Diabetes), born from the need to fill the gap between diabetes and cardiovascular diseases through new scientific and clinical research and real-world data. The imminent risk and role that diabetes plays in cardiovascular health is evidenced by new scientific research.

Worldwide CardioDiabetes aims to educate health care professionals on the interrelationship between diabetes and cardiovascular disease. Educational programs focus on:

  • The impact and risk of diabetes in cardiovascular diseases
  • The impact of cardiovascular diseases in patients with diabetes and other endocrine disorders
  • Therapeutic approaches to prevent and treat cardiovascular diseases related to diabetes
  • New scientific data related to diabetes and cardiovascular disease

Worldwide CardioDiabetes partners with societies, non-profit and for profit organizations alike and the large majority of our programs are made possible through unrestricted educational grants.



Cardiorenal syndrome (CRS) in people with type 2 diabetes mellitus illustrates the bidirectional link between the heart and the kidneys, with acute or chronic dysfunction of one organ adversely impacting the function of the other. The cardiovascular and renoprotective benefits evidenced with sodium-glucose transporter-2 (SGLT-2) inhibitors make them a potential choice in the management of CRS.

Join the Worldwide CardioDiabetes on-demand symposium, “Practical Applications in Managing Patients with CardioRenal Disease: New SBLT-2 Study Data”, to learn more about the results of recent studies and how to apply this knowledge to your daily practice. It will be available during the upcoming 76th Annual Brazilian Congress of Cardiology and thereafter on this website. You can register via https://congressosbc.associatec.com.br to view the program during the congress dates and check back here thereafter for open, on-demand access.

Click here to view the symposium faculty and agenda in full detail.